The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Abstract
Mammalian cells proteolytically release (shed) the extracellular domains of many cell-surface proteins. Modification of the cell surface in this way can alter the cell's responsiveness to its environment and release potent soluble regulatory factors. The release of soluble tumour-necrosis factor-alpha (TNF-alpha) from its membrane-bound precursor is one of the most intensively studied shedding events because this inflammatory cytokine is so physiologically important. The inhibition of TNF-alpha release (and many other shedding phenomena) by hydroxamic acid-based inhibitors indicates that one or more metalloproteinases is involved. We have now purified and cloned a metalloproteinase that specifically cleaves precursor TNF-alpha. Inactivation of the gene in mouse cells caused a marked decrease in soluble TNF-alpha production. This enzyme (called the TNF-alpha-converting enzyme, or TACE) is a new member of the family of mammalian adamalysins (or ADAMs), for which no physiological catalytic function has previously been identified. Our results should facilitate the development of therapeutically useful inhibitors of TNF-alpha release, and they indicate that an important function of adamalysins may be to shed cell-surface proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, ADAM17 (also known as TNF-α-converting enzyme) is of pivotal importance in the activation of TNF-α signaling32.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [32]
In the citing paper
“Finally, release of mature TNF from the plasmalemma requires cleavage of the membrane-bound precursor by the TNF-α-converting enzyme (TACE) (21).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [21]
Citations
Cites
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,281
Conditions controlling the proliferation of haemopoietic stem cells in vitro
Dexter, T. M., Allen, T., & Lajtha, L. G. (1977) · Journal of Cellular Physiology · doi:10.1002/jcp.1040910303 · Cited by 2,120
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon, J. J., Morrissey, P., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1955 · Cited by 1,553
Self-citationThe Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,221
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J. M., Davidson, A. H., Drummond, A. H., GALLOWAY, W. A., Gilbert, R. J. C., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Molecular Cloning of the Interleukin-1β Converting Enzyme
Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N. C., Ness, K. V., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., et al. (1992) · Science · doi:10.1126/science.1373520 · Cited by 1,147
Self-citationKriegler, M., Perez, C. F., DeFay, K., Albert, I., & Lu, S.-D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,090
Soluble receptors for cytokines and growth factors: generation and biological function
Rose‐John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 777
Mammalian subtilisins: The long-sought dibasic processing endoproteases
Barr, P. J. (1991) · Cell · doi:10.1016/0092-8674(91)90129-m · Cited by 750
Stöcker, W., Grams, F., Reinemer, P., Bode, W., Baumann, U., Gomis‐Rüth, F. X., & McKay, D. (1995) · Protein Science · doi:10.1002/pro.5560040502 · Cited by 725
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,007
Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration
Alfandari, D., Cousin, H., Gaultier, A., Smith, K., White, J. M., Darribère, T., & DeSimone, D. W. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00263-9 · Cited by 168
Role of ADAM17 in the ectodomain shedding of TNF-α and its receptors by neutrophils and macrophages
Bell, J. H., Herrera, A. H., Li, Y., & Walcheck, B. K. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307193 · Cited by 163
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
Kieseier, B. C. (1998) · Brain · doi:10.1093/brain/121.1.159 · Cited by 163
More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control
Bank, U., & Ansorge, S. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.2.197 · Cited by 163
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
Issuree, P. D. A., Maretzky, T., McIlwain, D. R., Monette, S., Qing, X., Lang, P. A., Swendeman, S. L., Park‐Min, K., Binder, N. B., Kalliolias, G. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66168 · Cited by 162
Hatakeyama, H., Cheng, H., Wirth, P. S., Counsell, A., Marcrom, S., Wood, C. B., Pohlmann, P. R., Gilbert, J., Murphy, B. A., Yarbrough, W. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012702 · Cited by 163
Shedding of interleukin‐6 receptor and tumor necrosis factor α
Althoff, K., Reddy, P., Voltz, N., Rose‐John, S., & Müllberg, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01278.x · Cited by 162
Self-citationMontero, J. C., Yuste, L., Dı́az-Rodrı́guez, E., Esparı́s-Ogando, A., & Pandiella, A. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0896 · Cited by 162
Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
Kwak, M. S., Kim, H. S., Lee, B., Kim, Y. H., Son, M., & Shin, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01189 · Cited by 167
Trafficking regulation of proteins in Alzheimer’s disease
Jiang, S., Li, Y., Zhang, X., Bu, G., Xu, H., & Zhang, Y. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-6 · Cited by 164
Function of an Axonal Chemoattractant Modulated by Metalloprotease Activity
Galko, M. J., & Tessier‐Lavigne, M. (2000) · Science · doi:10.1126/science.289.5483.1365 · Cited by 160
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A. F., Bursi, R., Perricone, R., & Gerli, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102468 · Cited by 158
Slack, B. E., Leona, K., & Seah, C. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570787 · Cited by 164
Rabolli, V., Badissi, A. A., Devosse, R., Uwambayinema, F., Yakoub, Y., Palmai-Pallag, M., Lebrun, A., De Gussem, V., Couillin, I., Ryffel, B., et al. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0069-x · Cited by 158
The fundamental role of mechanical properties in the progression of cancer disease and inflammation
Mierke, C. T. (2014) · Reports on Progress in Physics · doi:10.1088/0034-4885/77/7/076602 · Cited by 165
Li, Y. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00297-1 · Cited by 156
Zheng, Y., Säftig, P., Hartmann, D., & Blobel, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403193200 · Cited by 158
Murray, R. Z., Wylie, F. G., Khromykh, T., Hume, D. A., & Stow, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414420200 · Cited by 157
iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
Li, X., Maretzky, T., Weskamp, G., Monette, S., Qing, X., Issuree, P. D. A., Crawford, H. C., McIlwain, D. R., Mak, T. W., Salmon, J. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505649112 · Cited by 162
Proteases in brain tumour progression
Levičar, N., Nutall, R. K., & Lah, T. T. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-003-0097-z · Cited by 159
Extracellular Proteases in Atherosclerosis and Restenosis
García‐Touchard, A., Henry, T. D., Sangiorgi, G., Spagnoli, L. G., Mauriello, A., Conover, C. A., & Schwartz, R. S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000164311.48592.da · Cited by 157
Weskamp, G., Schlöndorff, J. S., Lum, L., Becherer, J. D., Kim, T., Säftig, P., Hartmann, D., Murphy, G., & Blobel, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307974200 · Cited by 160
de Rouvroit, C. L., de Bergeyck, V., Cortvrindt, C., Bar, I., Eeckhout, Y., & Goffinet, A. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7007 · Cited by 161
Milla, M. E., Leesnitzer, M. A., Moss, M. L., Clay, W. C., Carter, H. L., Miller, A. B., Su, J., Lambert, M. H., Willard, D. H., Sheeley, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30563 · Cited by 156
Kodama, T., Ikeda, E., Okada, A., Ohtsuka, T., Shimoda, M., Shiomi, T., Yoshida, K., Nakada, M., Ohuchi, E., & Okada, Y. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63429-3 · Cited by 156
TACE and other ADAM proteases as targets for drug discovery
Moss, M. L., White, J. M., Lambert, M. H., & Andrews, R. C. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01738-x · Cited by 158
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solórzano, C. C., Norman, J., Denham, W., Clare-Salzler, M. J., MacKay, S. L., et al. (1998) · PubMed · Cited by 156
Garbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., & Scheller, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.018 · Cited by 155
Disease Tolerance as an Inherent Component of Immunity
Martins, R., Carlos, A. R., Braza, F., Thompson, J. A., Bastos-Amador, P., Ramos, S., & Soares, M. P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041739 · Cited by 151
Tetraspanins Regulate ADAM10-Mediated Cleavage of TNF-α and Epidermal Growth Factor
Arduise, C., Abache, T., Li, L., Billard, M., Chabanon, A., Ludwig, A., Mauduit, P., Boucheix, C., Rubinstein, E., & Naour, F. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7002 · Cited by 154
Inflammatory cytokines: from discoveries to therapies in IBD
Marafini, I., Sedda, S., Dinallo, V., & Monteleone, G. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1652267 · Cited by 154
Stone, A. L., Kröger, M., & Sang, Q. A. (1999) · Journal of Protein Chemistry · doi:10.1023/a:1020692710029 · Cited by 161
Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives
Hoekstra, R., Eskens, F. A. L. M., & Verweij, J. (2001) · The Oncologist · doi:10.1634/theoncologist.6-5-415 · Cited by 154
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Moss, M. L., & Minond, D. (2017) · Mediators of Inflammation · doi:10.1155/2017/9673537 · Cited by 157
Targeting matrix metalloproteases to improve cutaneous wound healing
Xue, M., Le, N. T., & Jackson, C. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.143 · Cited by 153
Hinkle, C. L., Sunnarborg, S. W., Loiselle, D. R., Parker, C. E., Stevenson, M. C., Russell, W. E., & Lee, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312141200 · Cited by 156
Mohammed, F. F., Pennington, C. J., Kassiri, Z., Rubin, J. S., Soloway, P. D., Rüther, U., Edwards, D. R., & Khokha, R. (2005) · Hepatology · doi:10.1002/hep.20618 · Cited by 156
Enzyme-Instructed Self-Assembly: A Multistep Process for Potential Cancer Therapy
Zhou, J., & Xu, B. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00196 · Cited by 156
Tatti, O., Vehviläinen, P., Lehti, K., & Keski‐Oja, J. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.05.018 · Cited by 152
Galliano, M., Huet, C., Frygelius, J., Polgren, A., Wewer, U. M., & Engvall, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13933 · Cited by 152
Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis
Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solórzano, C. C., Norman, J., Denham, W., Clare-Salzler, M. J., MacKay, S. L. D., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4082 · Cited by 163
Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation
Smookler, D. S., Mohammed, F. F., Kassiri, Z., Duncan, G. S., Mak, T. W., & Khokha, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.721 · Cited by 154
The shedding activity of ADAM17 is sequestered in lipid rafts
Tellier, E., Canault, M., Rebsomen, L., Bonardo, B., Juhan-Vague, I., Nalbone, G., & Peiretti, F. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.027 · Cited by 155
Rovida, E., Paccagnini, A., Rosso, M. D., Peschon, J. J., & Sbarba, P. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1583 · Cited by 151
Self-citationImmunoregulatory role of TNFα in inflammatory kidney diseases
Ernandez, T., & Mayadas, T. N. (2009) · Kidney International · doi:10.1038/ki.2009.142 · Cited by 148
Extrinsic regulators of epithelial tumor progression: metalloproteinases
Bergers, G., & Coussens, L. M. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00043-x · Cited by 148
Chin, S. M., Kimberlin, C. R., Roe-Zurz, Z., Zhang, P., Xu, A., Liao-Chan, S., Sen, D., Nager, A. R., Oakdale, N. T. S., Brown, C. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07136-7 · Cited by 145
Duong, T. D., & Erickson, C. A. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10465 · Cited by 147
Pivarcsi, A., Nagy, I., Koreck, A., Kis, K., Kenderessy, A. S., Széll, M., DOBOZY, A., & Kemény, L. V. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.016 · Cited by 148
Kurisaki, T., Masuda, A., Sudo, K., Sakagami, J., Higashiyama, S., Matsuda, Y., Nagabukuro, A., Tsuji, A. B., Nabeshima, Y.-I., Asano, M., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.55-61.2003 · Cited by 155
Weskamp, G., Mendelson, K., Swendeman, S. L., Gall, S. M. L., Ma, Y., Lyman, S. L., Hinoki, A., Eguchi, S., Guaiquil, V. H., Horiuchi, K., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.207415 · Cited by 147
THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
Selkoe, D. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70232-2 · Cited by 146
DeClerck, Y. A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00094-0 · Cited by 144
Otsuka, A., Kubo, M., Honda, T., Egawa, G., Nakajima, S., Tanizaki, H., Kim, B., Matsuoka, S., Watanabe, T., Nakae, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025538 · Cited by 144
Velasco-Loyden, G., Arribas, J., & López‐Casillas, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306499200 · Cited by 144
Pasquereau, S., Kumar, A., & Herbein, G. (2017) · Viruses · doi:10.3390/v9040064 · Cited by 141
Molecular Mechanisms of Soluble Cytokine Receptor Generation
Levine, S. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700052200 · Cited by 143
The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition
Maymon, E., Ghezzi, F., Edwin, S. S., Mazor, M., Yoon, B. H., Gómez, R., & Romero, R. J. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70097-9 · Cited by 143
An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding
Cui, X., Rouhani, F. N., Hawari, F. I., & Levine, S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300456200 · Cited by 146
TNFR2: A Novel Target for Cancer Immunotherapy
Vanamee, É. S., & Faustman, D. L. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.09.007 · Cited by 142
Pei, D., Kang, T., & Qi, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006493200 · Cited by 142
Cell migration: mechanisms of rear detachment and the formation of migration tracks
Kirfel, G., Rigort, A., Borm, B., & Herzog, V. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00421 · Cited by 142
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144
Zhang, Q. H., Thomas, S. M., Lui, V. W. Y., Xi, S., Siegfried, J. M., Fan, H., Smithgall, T. E., Mills, G. B., & Grandis, J. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509719103 · Cited by 141
Espey, L. L., Yoshioka, S., Russell, D. L., Robker, R. L., Fujii, S., & Richards, J. S. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.4.1090 · Cited by 141
Crockett, J. C., Mellis, D. J., Scott, D. I., & Helfrich, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1272-8 · Cited by 143
ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets
Yildiz, D., Uhlig, S., & Ludwig, A. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00294.2014 · Cited by 145
Wang, Y., & Sul, H. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02437-05 · Cited by 140
Wehrhahn, J., Kraft, R., Harteneck, C., & Hauschildt, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902474 · Cited by 140
Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives
Chia, J., Goh, G. Y. L., & Bard, F. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.008 · Cited by 143
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
Murillo, M. M., del Castillo, G., Sánchez, A., Fernández, M., & Fabregat, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208664 · Cited by 140
Zhang, Y., Jiang, J., Black, R. A., Baumann, G. P., & Frank, S. J. (2000) · Endocrinology · doi:10.1210/endo.141.12.7858 · Cited by 140
Self-citationBlanchot‐Jossic, F., Jarry, A., Masson, D., Bach‐Ngohou, K., PAINEAU, J., Denis, M. G., LABOISSE, C. L., & Mosnier, J. (2005) · The Journal of Pathology · doi:10.1002/path.1814 · Cited by 143
Sheets, S. M., Potempa, J., Travis, J. W., Casiano, C. A., & Fletcher, H. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1543-1552.2005 · Cited by 139
Schlomann, U., Rathke‐Hartlieb, S., Yamamoto, S., Jockusch, H., & Bartsch, J. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07964.2000 · Cited by 139
Generation of Human Soluble Leptin Receptor by Proteolytic Cleavage of Membrane-Anchored Receptors
Maamra, M., Bidlingmaier, M., Postel-Vinay, M. C., Wu, Z., Strasburger, C. J., & Ross, R. J. M. (2001) · Endocrinology · doi:10.1210/endo.142.10.8442 · Cited by 140
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271018 · Cited by 139
García‐Castillo, J., Pelegrı́n, P., Mulero, V., & Meseguer, J. (2002) · Immunogenetics · doi:10.1007/s00251-002-0451-y · Cited by 139
Metalloproteinases, inflammation, and rheumatoid arthritis
Mohammed, F. F., Smookler, D. S., & Khokha, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii43 · Cited by 141
Reiß, K., Ludwig, A., & Säftig, P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.009 · Cited by 136
Yang, Z. F., Ho, D. W., Lau, C. K., Lam, C. T., Lum, C. T., Poon, R. T. P., & Fan, S. T. (2005) · International Immunology · doi:10.1093/intimm/dxh316 · Cited by 138
Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01223-7 · Cited by 137
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure
Moore, L. E., Dong, F., Basu, R., Kandalam, V., & Kassiri, Z. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9266-y · Cited by 139
Loss of Lymphotoxin-α but Not Tumor Necrosis Factor-α Reduces Atherosclerosis in Mice
Schreyer, S. A., Vick, C. M., & LeBoeuf, R. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111727200 · Cited by 137
Wasserman, J. K., Zhu, X., & Schlichter, L. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.058 · Cited by 137
Möller‐Hackbarth, K., Dewitz, C., Schweigert, O., Trad, A., Garbers, C., Rose‐John, S., & Scheller, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.488478 · Cited by 141
Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding
Wang, Y., Herrera, A. H., Li, Y., Belani, K., & Walcheck, B. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802770 · Cited by 136
Wound-Induced HB-EGF Ectodomain Shedding and EGFR Activation in Corneal Epithelial Cells
Xu, K.-P., Ding, Y., Ling, J., Dong, Z., & Yu, F. X. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0851 · Cited by 136
Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-α-converting Enzyme
Contin‐Bordes, C., Pitard, V., Itai, T., Nagata, S., Moreau, J., & Déchanet‐Merville, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209993200 · Cited by 135
Asthma is associated with single‐nucleotide polymorphisms in ADAM33
Werner, M., Herbon, N., Gohlke, H., Altmüller, J., Knapp, M., Heinrich, J., & Wjst, M. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01846.x · Cited by 130
Hua, Y., Wu, J., Keep, R. F., Nakamura, T., Hoff, J. T., & Xi, G. (2006) · Neurosurgery · doi:10.1227/01.neu.0000197333.55473.ad · Cited by 133
The ADAMs family: Coordinators of nervous system development, plasticity and repair
Yang, P., Baker, K. A., & Hagg, T. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.05.001 · Cited by 116
Matrix metalloproteinase inhibitors 1998
Beckett, R. P., & Whittaker, M. A. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.3.259 · Cited by 133
Fleck, D., van Bebber, F., Colombo, A., Galante, C., Schwenk, B. M., Rabe, L., Hampel, H., Novak, B., Kremmer, E., Tahirovic, S., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3372-12.2013 · Cited by 123
Quinolines: a new hope against inflammation
Mukherjee, S., & Pal, M. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.003 · Cited by 132
Functions of ‘A disintegrin and metalloproteases (ADAMs)’ in the mammalian nervous system
Hsia, H., Tüshaus, J., Brummer, T., Zheng, Y., Scilabra, S. D., & Lichtenthaler, S. F. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03173-7 · Cited by 148
Metalloprotease-Disintegrin (ADAM) Genes Are Widely and Differentially Expressed in the Adult CNS
Kärkkäinen, I., Rybnikova, E. A., Pelto‐Huikko, M., & Huovila, A. J. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0848 · Cited by 132
Matrix Metalloproteinase Inhibition: From The Jurassic To The Third Millennium
Woessner, J. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07697.x · Cited by 132
ADAM family proteins in the immune system
Yamamoto, S., Higuchi, Y., Yoshiyama, K., Shimizu, E., Kataoka, M., Hijiya, N., & Matsuura, K. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01464-4 · Cited by 132
Diverse regulatory roles for lysosomal proteases in the immune response
Colbert, J. D., Matthews, S. P., Miller, G., & Watts, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200939650 · Cited by 131
Metadata
- Authors
- Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., & Cerretti, D. P.
- Venue
- Nature
- Published
- 1997-02
- Volume
- 385
- Issue
- 6618
- Pages
- 729-733
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2074881372
- Cited by
- 3,149
- References
- 30
- Citations by year
- 2026: 47 · 2025: 45 · 2024: 52 · 2023: 58 · 2022: 97 · 2021: 105 · 2020: 100 · 2019: 88 · 2018: 95 · 2017: 98 · 2016: 97 · 2015: 92 · 2014: 114 · 2013: 124 · 2012: 115
- FWCI
- 60.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, TNF-alpha converting enzyme, transarterial chemoembolization, metalloproteinases, ADAMS, protein shedding, soluble TNF-alpha, hydroxamate inhibitors, gene inactivation, cytokine production, inflammatory cytokines
- MeSH terms
- ADAM17 Protein, Amino Acid Sequence, Animals, Cattle, Cell Membrane, Cloning, Molecular, Enzyme Precursors, Humans, Metalloendopeptidases, Mice, Inbred C57BL, Molecular Sequence Data, Solubility, T-Lymphocytes, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Zinc, Polymerase Chain Reaction, Gene Targeting, Disintegrins, Mice, ADAM Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review